Melanotan II peptide
Melanotan II is a synthetic peptide developed as an analogue of a naturally occurring hormone involved in skin pigmentation and melanocyte activity. It was originally investigated for its ability to stimulate melanin production and protect the skin from ultraviolet (UV) radiation.
Melanotan II peptide is structurally related to Alpha-melanocyte-stimulating hormone, a hormone that regulates pigmentation through the melanocortin receptor system.
Although Melanotan II has been studied in scientific research, it is considered an experimental compound and has not been approved as a prescription medication by major regulatory authorities.
How Melanotan II peptide works
Melanotan II acts as an agonist of melanocortin receptors, particularly the MC1R receptor involved in melanin production in the skin. Research suggests that the peptide may:
stimulate melanin production in melanocytes
promote skin pigmentation independent of UV exposure
activate melanocortin receptors involved in appetite, metabolism, and sexual function
Because melanocortin receptors are distributed throughout the body, activation of these pathways may influence several physiological processes beyond skin pigmentation.
This receptor activity is also the reason why researchers observed additional effects related to sexual arousal and appetite regulation in experimental studies.
Clinical trials and evidence
Melanotan II peptide was originally developed as part of research investigating ways to increase skin pigmentation and reduce UV-related skin damage. Early clinical studies examined:
stimulation of melanin production in human skin
the potential role of melanocortin receptor agonists in photoprotection
During clinical trials, researchers observed additional physiological effects, including changes in sexual arousal, which later led to the development of related compounds such as Bremelanotide.
Despite its biological activity, Melanotan II itself did not progress to pharmaceutical approval, and most available information comes from experimental research and early clinical studies.
Possible side effects of Melanotan II peptide:
Because Melanotan II activates melanocortin receptors throughout the body, it may produce a range of physiological effects. Reported or possible side effects include:
nausea
flushing
increased skin pigmentation
darkening of existing moles or freckles
fatigue or changes in appetite
The long-term safety profile has not been fully established, particularly outside controlled research settings.